Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway. [PDF]
Exp Dermatol, 2022 Mastocytosis is a KIT‐related myeloproliferative disease characterised by abnormal expansion of neoplastic mast cells (MC) in the skin or virtually any other organ system.
Lampinen M +8 more
europepmc +2 more sources
COVID-19 Vaccines Are Safely Tolerated in Adolescents with Cutaneous Mastocytosis [PDF]
International Archives of Allergy and Immunology, 2023 Introduction: The management of the COVID-19 vaccine in children with mastocytosis is unclear due to a lack of data. In the current study, we aimed to evaluate the adverse reactions following COVID-19 vaccination in adolescents with cutaneous ...
Hande Yüksel Bulut +2 more
openalex +2 more sources
Case Report and Review of the Literature: Bullous Skin Eruption After the Booster-Dose of Influenza Vaccine in a Pediatric Patient With Polymorphic Maculopapular Cutaneous Mastocytosis. [PDF]
Front Immunol, 2021 Vaccination is a well-known trigger for mast cell degranulation in subjects affected by mastocytosis. Nevertheless, there is no exact standardized protocol to prevent a possible reaction after a vaccine injection, especially for patients who have already
Sarcina D +12 more
europepmc +2 more sources
-2518A/G polymorphism of monocyte chemotactic protein 1 (MCP-1/CCL2) is associated with cutaneous mastocytosis. [PDF]
Postepy Dermatol Alergol, 2021 Introduction Mastocytosis is a rare heterogeneous disease associated with pathological accumulation of mast cells (MCs) in one or more organs. The disease may be limited to the skin (cutaneous mastocytosis – CM), or present an internal organ involvement (
Ługowska-Umer H +5 more
europepmc +2 more sources
Pathomorphology of cutaneous mastocytosis
Meditsinskiy sovet = Medical Council, 2023 Introduction. Mastocytosis as a result of mast cell infiltration of the skin and other organs develops at any age. The relevance of this work is determined by the lack of systematic data on the pathomorphological features of the clinical forms and types ...
Е. И. Касихина +5 more
openalex +3 more sources
OncohematologyBackround. Mastocytosis is a rare disease characterized by pathological accumulation of mast cells in one or more organs. According to the world Health Organization classification (2016), a monomorphic type of maculopapular cutaneous mastocytosis ...
Е. И. Касихина +3 more
openalex +3 more sources
Congenital cutaneous mastocytosis mistaken for non-accidental injury. [PDF]
Pediatr Investig, 2023 Porter E +3 more
europepmc +3 more sources
Successful treatment of provisional cutaneous mastocytosis with interferon alpha
Indian Journal of Dermatology, 2016 Mastocytosis is a disorder characterized by the clonal proliferation of mast cells and their accumulation in skin, bone marrow, liver, and spleen. Cutaneous mastocytosis presents in children in over 90% of the cases and any cutaneous manifestation in an ...
Andrea Rosario, Ramesh M Bhat
doaj +2 more sources
French guidelines for the management of nonadvanced mastocytosis in adults [PDF]
Orphanet Journal of Rare DiseasesMastocytosis is a rare disease caused by abnormal mast cell accumulation/proliferation in various organs/tissues. Its clinical features exhibit significant variability irrespective of its clinical presentation, classification, global survival or impact ...
Cristina Bulai Livideanu +5 more
doaj +2 more sources
Avapritinib for Cutaneous Mastocytosis. [PDF]
Acta Derm Venereol, 2021 Lee H +4 more
europepmc +4 more sources